Although accumulating evidence has indicated the intimate association between epithelial-mesenchymal transition (EMT) and acquired resistance to chemotherapy for colorectal cancer (CRC), the underlying mechanisms remain elusive. Herein, we reported that Snail, a crucial EMT controller, was upregulated in CRC tissues. Colorectal cancer cells overexpressing Snail were found to be more resistant to 5-fluorouracil (5-Fu). Mechanistic studies reveal that Snail could increase the expression of ATP-binding cassette subfamily B member 1 (ABCB1) rather than the other 23 chemoresistance-related genes. Additionally, knockdown of ABCB1 significantly attenuated Snail-induced 5-Fu resistance in CRC cells. Oxaliplatin increased Snail and ABCB1 expression in CRC cells. Snail and ABCB1 were upregulated in 5-Fu-resistant HCT-8 (HCT-8/5-Fu) cells and inhibition of Snail decreased ABCB1 in HCT-8/5-Fu cells. These results confirm the vital role played by ABCB1 in Snail-induced chemoresistance. Further investigation into the relevant molecular mechanism revealed Snail-mediated ABCB1 upregulation was independent of β-catenin, STAT3, PXR, CAR and Foxo3a, which are commonly involved in modulating ABCB1 transcription. Instead, Snail upregulated ABCB1 transcription by directly binding to its promoter. Clinical analysis confirms that increased Snail expression correlated significantly with tumor size (P = .018), lymph node metastasis (P = .033), distant metastasis (P = .025), clinical stage grade (P = .024), and poor prognosis (P = .045) of CRC patients. Moreover, coexpression of Snail and ABCB1 was observed in CRC patients. Our study revealed that direct regulation of ABCB1 by Snail S U PP O RTI N G I N FO R M ATI O N Additional supporting information may be found online in the Supporting Information section. How to cite this article: Wang H, Li J-M, Wei W, et al. Regulation of ATP-binding cassette subfamily B member 1 by Snail contributes to chemoresistance in colorectal cancer.
was critical for conferring chemoresistance in CRC cells. These findings unraveled the mechanisms underlying the association between EMT and chemoresistance, and provided potential targets for CRC clinical treatment.
| INTRODUC TI ON
The epithelial-mesenchymal transition (EMT) is an important phenotypic conversion that occurs at the invasive front of many metastatic cancers. [1] [2] [3] Several transcription factors, including Snail, Slug, Twist, and ZEB1, trigger the EMT by restraining the expression of E-cadherin. 4, 5 Snail is overexpressed in various metastatic cancer cells and has been identified as a crucial regulator of the EMT. 6, 7 Clinically, patients with metastatic tumors are more resistant to chemotherapy and have a poor therapeutic response. Emerging evidence suggests that the EMT phenotype is associated with the acquisition of chemoresistance in cancer cells. For instance, overexpression of Twist contributes to chemoresistance in breast cancer cells and colorectal cancer (CRC) cells. 8, 9 It has been shown that ZEB1 can promote the resistance of pancreatic cancer cells to cisplatin, gemcitabine, and 5-fluorouracil (5-Fu). 10 Moreover, the susceptibility of cancer cells with the mesenchymal phenotype to chemotherapeutic agents is markedly lower than that of cancer cells with the epithelial phenotype. 11 We have previously reported that lung cancer cells resistant to cisplatin acquire an EMT phenotype and cancer stem cell-like properties. 12 Taken together, these studies indicate a correlation between the EMT and chemoresistance. However, the underlying mechanisms are still unclear.
Tumor metastasis and the development of chemoresistance are responsible for the mortality due to CRC, one of the leading causes of cancer-driven death. Despite the efficacy of initial chemotherapy for most CRC patients, the response rate significantly decreases with the length of treatment. Hence, there is an urgent demand for elucidating the molecular mechanisms of tumor metastasis and chemoresistance, which is important for exploring innovative remedies.
The molecular mechanisms involved in the development of chemoresistance are highly complicated and include decreased intracellular accumulation of drugs, suppression of cell apoptosis, overexpression of DNA repair enzymes, and activation of DNA damage checkpoint responses. 13, 14 Among these, ATP-binding cassette (ABC) membrane transport protein-mediated efflux of intracellular cytotoxic agents has been proven to be one of the most important factors regulating chemoresistance. 15, 16 The first discovered ABC transporter, ABCB1, also known as multidrug resistance protein 1 (MDR1), is capable of exporting a variety of antitumor drugs out of cancer cells and thereby inducing multidrug resistance. 17, 18 Importantly, mounting studies have indicated that ABCB1 overexpression culminates in chemotherapy failure in a wide variety of cancer cells, exemplified by CRC cells. 19, 20 Our group has been continuously dedicated to research of the molecular mechanisms associated with chemoresistance in cancer therapy. We previously uncovered the role of Snail in controlling the EMT phenotype and cancer stem cell features in cisplatin-resistant lung cancer cells. 12 Considering the mortality of chemoresistant CRC, the present study has focused on an unexplored mechanism, namely, how Snail-overexpressing CRC evades treatment with cytotoxic agents, in an attempt to better understand the association of the EMT with chemoresistance.
| MATERIAL S AND ME THODS

| Chemicals and reagents
The SimpleChIP Enzymatic Chromatin IP Kit and primary Abs against ABCB1, Foxo3a, and STAT3 were obtained from Cell Signaling Technology. Human Snail Ab was purchased from R&D Systems.
Primary Abs against β-catenin, pregnane X receptor (PXR), constitutive androstane receptor (CAR), and α-tubulin were obtained from Santa Cruz Biotechnology. The PrimeScript RT Reagent Kit and SYBR Premix Ex Taq were purchased from Takara Bio. Smartpool siRNA against ABCB1 was obtained from RiboBio. Vectors (pGL3-Basic, pcDNA3.1, and pRL-TK) and a dual-luciferase assay kit were purchased from Promega.
| Cell culture
The cell lines HCT116, HT29, SW480, HCT-8, and HEK293T were obtained from the Type Culture Collection of the Chinese Academy of Sciences. The human CRC-resistant cell line HCT-8/5-Fu was established in our laboratory. Briefly, HCT-8 cells were treated with a series of stepwise-increased concentrations of 5-Fu to develop a HCT-8/5-Fu-resistant cell line. HCT116 and HT29 cells were maintained in DMEM/F12 culture medium supplemented with 10% FBS, SW480 and HEK293T cells were cultured in DMEM culture medium supplemented with 10% FBS, and HCT-8 and HCT-8/5-Fu cells were maintained in RPMI-1640 culture medium supplemented with 10% FBS under a humidified 5% CO 2 atmosphere at 37°C in an incubator.
| Quantitative real-time PCR
After treatment for the indicated time, the total mRNA of cells was extracted with TRIzol reagent and 500 ng RNA was used for cDNA synthesis. Quantitative real-time PCR using the SYBR Premix Ex Taq real-time PCR system (Takara Bio) was applied to quantify K E Y W O R D S ABCB1, chemoresistance, colorectal cancer, EMT, Snail the expression of target genes on an ABI 7500 system (Applied Biosystems). GAPDH was selected as the reference gene. The sequences of the primers used in the real-time PCR experiments are shown in Table 1 .
| Western blot analysis
After being washed with ice-cold PBS, the cells were lysed and harvested. Equal amounts of protein samples were loaded on SDSpolyacrylamide gels and then transferred onto PVDF membranes.
After being blocked with 5% blocking buffer at room temperature for 2 hours, the membranes were probed with primary Abs at 4°C overnight and then incubated with secondary Abs for 1.5 hours at room temperature. The signals of specific immune complexes were detected using electrochemiluminescence reagent. and ABCB1-mut1-R, ACTTAGATCGCAGATCTCGAGGAGTATTTG TACCTTACC. The sequence of the E-box motif is "CAAATG" (−577 to −571), and the sequence of mutated E-box motif is "GTTTAC".
| Dual-luciferase reporter assay
| Cell viability assay
Cell viability was measured by using the CCK-8 agent. Briefly, cells were seeded in 96-well plates at a density of 1 × 10 4 cells/well and treated with different concentrations of 5-Fu for 48 hours. The 10 μL CCK-8 agent was added to each well and the plates were incubated for 4 hours at 37°C. The absorbance was detected at 570 nm using a microplate reader. All experiments were carried out in triplicate. 
| Chromatin immunoprecipitation assay
| Immunohistochemistry
Colorectal cancer tumor tissues were collected from 46 patients at Throughout the above analyses, controls were prepared by omitting the primary Abs.
The expression levels of Snail and ABCB1 were independently evaluated by 2 pathologists. The tumor cells with brown cytoplasm, nucleus, or membrane were considered positive. These cells were scored and then classified into the following 4 classes: none (0), weak brown (1+), moderate brown (2+), and strong brown (3+). The percentage of the stained tumor cells was divided into the following 5 classes: 0, negative cells; 1, 1%-25%; 2, 25%-50%; 3, 50%-75%;
and 4, >75%. The multiplication (staining index) of the intensity and percentage scores was used to determine the result. 
| Database search
| Statistical analysis
Results are expressed as the mean ± SD of 3 independent experiments unless otherwise specified. Differences between any 2 groups were analyzed by a 2-tailed unpaired Student's t test. Oneway ANOVA was used to assess the difference in means among groups. Pearson's χ 2 test was used to measure the expression difference of Snail in CRC tumor samples and adjacent normal tissues.
The Wilcoxon test and Kruskal-Wallis test were used to assess the correlations between expression levels of Snail and clinicopathological characteristics of CRC. The Wilcoxon test was used to assess the difference between 2 groups and the Kruskal-Wallis test was used to assess the difference in means among groups. Survival curves were generated using the Kaplan-Meier method. Pearson's correlation coefficient test was used to assess the correlation between 2 continuous variables. These analyses were carried out using GraphPad Prism version 5.0 software (GraphPad Software). P < .05 was considered statistically significant.
| RE SULTS
| Snail is upregulated in CRC and predicts poor survival of patients
We first investigated the expression of Snail in 46 pairs of CRC tumor samples and its matched adjacent normal tissues. The results of immunohistochemistry showed that Snail expression was significantly increased in CRC tumor samples compared to adjacent normal tissues ( Figures 1A and S1 ). We analyzed TCGA and GEO patient databases and found that Snail mRNA expression was higher in CRC tissues than in normal tissues ( Figure 1B ,C). The GEO data showed that expression of Snail in CRC was significantly higher than their matched adjacent normal tissues ( Figure 1D ).
Furthermore, TGGA data showed the association between Snail expression and clinicopathologic variables of CRC. As shown in high Snail expression was associated with poor prognosis of CRC patients ( Figure 1I ).
| Overexpression of Snail induces 5-Fu resistance and increases ABCB1 expression in CRC cells
Emerging evidence shows that the EMT phenotype is associated with acquired chemoresistance in cancer cells. 21 To explore the correlation between the EMT phenotype and drug resistance, we overexpressed Snail in CRC cells. As shown in Figure 2A 16 The DNA repair enzymes, including ERCC1/2 and XRCC1, have shown to be involved in chemoresistance in cancers. [22] [23] [24] Mcl-1 is a protein involved in suppression of cell apoptosis. A study showed that
Mcl-1 can modulate drug resistance in cancer cells. 25 DNA damage checkpoint response proteins, including BRCA1/2, MSH2/6, and GADD45α/β, have shown to be involved in chemoresistance in cancers. [26] [27] [28] [29] [30] Both GST and TUBB3 can also modulate drug resistance in cancer cells. 31, 32 To investigate the underlying mechanism of chemoresistance induction by Snail, we measured expression patterns of these chemoresistance-related genes in Snail-overexpressing CRC cells. The result of quantitative real-time PCR (qRT-PCR) showed that overexpression of Snail upregulated the mRNA expression of ABCB1 but had no significant effect on that of ABCC1/2/3/4/5/6/10/11/12, ABCG2,
GADD45α/β ( Figure 2D ). In addition, overexpression of Snail increased ABCB1 protein expression in both HCT116 and SW480 cells, but not ABCC1/2/3/12, ABCG2, or ERCC1 ( Figure 2E ). We also found that overexpression of Snail decreased the mRNA and protein expression of E-cadherin, which is a hallmark of EMT ( Figure 2D ,E), suggesting that overexpression of Snail could induce the EMT in CRC cells.
| Snail-mediated ABCB1 upregulation
is independent of β-catenin, Foxo3a, STAT3, PXR, and CAR Next, we probed the molecular mechanism of Snail-mediated ABCB1 upregulation. Several transcription factors, such as β-catenin, Foxo3a, STAT3, PXR, and CAR, affect ABCB1 expression by directly binding to its promoter. [33] [34] [35] [36] [37] Thus, we investigated whether Snail could influence their activities by detecting the mRNA and protein expression of these transcription factors by qRT-PCR and western blot analysis. Unfortunately, we found that Snail had no significant effect on the mRNA and protein expression levels of β-catenin, Foxo3a, STAT3, PXR, or CAR ( Figure 3A,B) , suggesting the presence of an alternative mechanism for Snail-mediated ABCB1 upregulation.
| Snail directly regulates ABCB1 transcription
We envisioned that Snail, as a transcription factor, might directly regulate ABCB1 transcription. To confirm the hypothesis, we searched the -1000 to +180 bp region of the ABCB1 promoter and analyzed the possible binding sites (E-box, consensus sequence: CANNTG, N, random bases). There were 5 possible Snail-binding sites in the promoter region of the ABCB1 gene ( Figure 3C ). We first constructed 5 promoter reporter plasmids (ABCB1 LucA, ABCB1 LucB, ABCB1 LucC, ABCB1 LucD, and ABCB1 LucE), which contained different lengths of the ABCB1 promoter ( Figure 4A ). There were 5 E-boxes in ABCB1 LucA, 4 in ABCB1 LucB, 3 in ABCB1 LucC, 2 in ABCB1 LucD, and 1 in Figure 4C ) and ChIP-qPCR was used to quantify the binding affinity of Snail ( Figure 4D ).
Collectively, these results revealed that Snail promoted ABCB1 expression by directly binding to its promoter region and that the E-box1 motif in the regulatory region played an important role in the promoter activation.
| ABCB1 is crucial for Snail-mediated 5-Fu resistance in CRC cells
We further investigated the role of ABCB1 in the Snail-mediated chemoresistance of CRC cells to 5-Fu. After transfection of HCT116 cells with si-ABCB1 and si-negative control, the expression of ABCB1 was detected by western blot analysis and RT-PCR. The results showed clear suppression of ABCB1 expression in HCT116 cells transfected with si-ABCB1 ( Figure 5A,B) . A cell viability assay was then performed to elucidate the role of ABCB1 in Snail-mediated chemoresistance to 5-Fu. As shown in 
F I G U R E 4
Direct regulation of ATP-binding cassette subfamily B member 1 (ABCB1) by Snail. A, Left, a series of deletion mutants of the ABCB1 promoter. TSS, transcription start site. Right, ABCB1-LucA, ABCB1-LucB, ABCB1-LucC, ABCB1-LucD, and ABCB1-LucE were transfected into HEK293T cells with or without Vector and Snail for 48 h. The cells were subjected to the luciferase reporter assay as described. B, Left, WT and mutated E-box in the ABCB1 promoter. Right, ABCB1-LucA and ABCB1-LucA (mE1) were transfected into HEK293T cells with or without Vector and Snail for 48 h. Cells were subjected to the luciferase reporter assay as described. C, ChIP assay was carried out using anti-Snail Ab or irrelevant anti-IgG Ab as a negative control. The protein-chromatin immunoprecipitates were subjected to PCR analysis as described. D, ChIP assay was carried out using anti-Snail Ab or irrelevant anti-IgG Ab as a negative control. The chromatin was subjected to quantitative PCR analysis. *P < .05; # P < .01
| Expression of Snail and ABCB1 are significantly relative in CRC patients
Accumulating reports show that patients with Snail-overexpressing CRC are more inclined to develop distant metastases and have a poor response to chemotherapy. 38, 39 Similarly, abundant ABCB1 expression is associated with CRC prognosis. 20 To determine the expression of Snail and ABCB1 in CRC patients and their contribution to chemoresistance, we used immunohistochemistry to investigate the expression of Snail and ABCB1 in 46 tumor samples from CRC patients. Two representative cases are shown in Figure 6A . In CRC tumor samples, Snail expression was evident in 29 cases (63.04%) and ABCB1 expression was seen in 24 cases (52.17%). There was a clear correlation between Snail and ABCB1 expression ( Figure 6B ). Moreover, we analyzed the GEO database and found that the expression of Snail was positively correlated with the ABCB1 mRNA in 211 CRC patients ( Figure 6C ).
The results from TCGA patient data further confirmed the coexpression of Snail and ABCB1 ( Figure 6D ). We then investigate the expression of ABCB1 in CRC tumor samples and normal tissues.
We analyzed the GEO patient database and found that ABCB1 mRNA expression was higher in CRC tissues than in normal tissues ( Figure 6E ). Moreover, high ABCB1 expression was associated with poor prognosis of CRC patients ( Figure 6F ). Collectively, these results suggested that activation of the Snail/ABCB1 axis promotes chemoresistance.
| D ISCUSS I ON
Increasing evidence shows that the EMT, which endows cancer cells with invasive and metastatic characteristics, is associated with acquired malignant phenotypes, such as induction of cancer stem-like features, 40 radiotherapy and chemotherapy resistance, [41] [42] [43] immunosuppression, 1 and angiogenesis. 44, 45 The pleiotropic activations triggered by EMT controllers give rise to complex behavior of cancer cells, which could be responsible for the difficulties encountered during treatment for metastatic cancers. However, very few studies have investigated the underlying mechanisms of EMT-mediated chemoresistance.
Herein, we found that the transcription factor Snail, which mediates the EMT, also regulates the expression of the multidrug-resistant transporter protein ABCB1. In particular, we identify that is a direct target of Snail.
We previously found that cisplatin-resistant lung cancer cells show EMT and cancer stem-like properties, with Snail playing an important role in maintaining the aggressive phenotype. 12 In this study, we further investigated the underlying molecular mechanisms of Snail-induced chemoresistance. Twenty-four drug resistance-related genes were examined in this study, including the ABC transport proteins ABCB1, ABCC1/2/3/4/5/6/10/11/12, and ABCG2, the DNA repair proteins ERCC1/2 and XRCC1, the antiapoptosis protein Mcl-1, and the DNA damage checkpoint proteins BRCA1/2 and MSH2/6. We found that Snail upregulated ABCB1
and not the other genes, suggesting that the other genes are not regulated by Snail in CRC cells. Some of these genes have possible Snail-binding sites in their promoter region, such as ERCC1 and ABCC4. Research has shown that Snail induces cisplatin resistance in head and neck squamous cell carcinoma by upregulation of ERCC1. 22 More recently, a study reported that Twist increases the expression of ABCC4 and ABCC5 in breast cancer cells. 46 The ABC family-mediated efflux results in multidrug resistance by pumping chemotherapeutic drugs out of cancer cells. 16 The most important member of the ABC transporter protein family, ABCB1, is F I G U R E 5 ATP-binding cassette subfamily B member 1 (ABCB1) is crucial for Snail-mediated 5-fluorouracil (5-Fu) resistance. A,B, HCT116 cells were transfected with si-negative (si-NC) or si-ABCB1 with Vector or Snail for 48 h. The protein expression and mRNA expression of ABCB1 were detected by western blot analysis and RT-PCR. C, HCT116 cells were transfected with si-negative (si-NC) or si-ABCB1 with Vector or Snail for 48 h. Cell viability was determined by CCK-8 assay. D,E, HCT116 cells were treated with oxaliplatin (5 μg/ mL) for 48 h and the mRNA (D) and protein (E) expression levels of Snail and ABCB1 were detected by RT-PCR and western blot analysis, respectively. F,G, mRNA (F) and protein (G) expression levels of Snail and ABCB1 in HCT-8 and HCT-8/5-Fu were detected by RT-PCR and western blot analysis, respectively. H,I, HCT-8/5-Fu cells were transfected with si-NC or si-Snail for 48 h. mRNA (H) and protein (I) expression levels of Snail and ABCB1 were detected by RT-PCR and western blot analysis, respectively. α-Tubulin served as the loading control.*P < .05; # P < .01 linked to various factors that induce multidrug resistance. Despite the well-defined role of ABCB1 in chemoresistance, most previous studies have focused on gene polymorphisms and mutations in ABCB1 while ignoring its regulatory mechanisms. [47] [48] [49] Additionally, a few transcription factors have been reported to directly interact with the promoter of ABCB1 and induce its expression, such as β-catenin, Foxo3a, STAT3, PXR, and CAR. [33] [34] [35] 37 However, in the present study, we found that none of these transcription factors were affected by Snail. Importantly, we found that Snail directly regulates ABCB1 transcription by binding to the E-box motif in the promoter of ABCB1. Given that the SANG domain has been reported to be involved in transcriptional regulation of the target gene of Snail, 50,51 it will be valuable to further investigate the role of the SANG domain in ABCB1 transcription regulation.
Our study revealed that, beyond invasion and metastasis, the EMT regulator Snail could induce chemoresistance by directly upregulating the ABC transporter ABCB1. Our results provide a better understanding of the molecular mechanism underlying cancer metastasis and chemoresistance. The Snail/ABCB1 axis could be a potential CRC therapeutic target for simultaneously addressing cancer metastasis and chemoresistance. 
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